Pharmaceutical Contract Manufacturing Market Research Report: Market size, Industry outlook, Market Forecast, Demand Analysis,Market Share, Market Report 2018-2023
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Pharmaceutical Contract Manufacturing Market
Pharmaceutical Contract Manufacturing Market: By Type (Active Pharmaceutical Ingredients (API), OTC Medicines, Others), By Drug Type (Solid, Liquid and Semi-Solid, Injection Dose Formulations) & By Region - Forecast(2018 - 2023)
Report Code : HCR 0308
Updated Date: 31 May, 2018  

1. Pharmaceutical Contract Manufacturing Market – Market Overview
2. Executive Summary
3. Market Landscape

   3.1. Market Share Analysis
   3.2. Comparative Analysis
   3.3. Product Benchmarking
   3.4. End User Profiling
   3.5. Top 5 Financials Analysis
4. Pharmaceutical Contract Manufacturing Market– Market Forces
   4.1. Drivers
      4.1.1. global economic constraints has led to increase in cost issues
      4.1.2. Rising demand for generic drugs
   4.2. Restraints
      4.2.1. Increasing lead time & logistics costs
   4.3. Opportunities
      4.3.1. Emerging economies
   4.4. Challenges
   4.5. Porter’s Five Forces Analysis
      4.5.1. Bargaining Power of Suppliers
      4.5.2. Bargaining Power of Buyers
      4.5.3. Threat of New Entrants
      4.5.4. Threat of Substitutes
      4.5.5. Degree of Competition
5. Pharmaceutical Contract Manufacturing Market– Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Pricing Analysis
   5.3. Opportunities Analysis
   5.4. Product/Market Life Cycle Analysis
   5.5. Suppliers and Distributors
6. Pharmaceutical Contract Manufacturing Market, By Type
   6.1. Advanced Drug Delivery Products
   6.2. Active Pharmaceutical Ingredients (API)
   6.3. OTC Medicines
   6.4. Nutritional products
   6.5. Final Dosage Form (FDF)
   6.6. Packaging Contract Manufacturing
7. Pharmaceutical Contract Manufacturing Market, By Drug Type
   7.1. Solid Dose Formulations
   7.2. Liquid and Semi-Solid Dose Formulations
   7.3. Injection Dose Formulations
8. Pharmaceutical Contract Manufacturing Market, By Geography
   8.1. Europe
      8.1.1. Germany
      8.1.2. France
      8.1.3. Italy
      8.1.4. Spain
      8.1.5. Russia
      8.1.6. U.K.
      8.1.7. Rest of Europe
   8.2. Asia Pacific
      8.2.1. China
      8.2.2. India
      8.2.3. Japan
      8.2.4. South Korea
      8.2.5. Rest of Asia-Pacific
   8.3. North America
      8.3.1. U.S.
      8.3.2. Canada
      8.3.3. Mexico
   8.4. Rest of the World (RoW)
      8.4.1. Brazil
      8.4.2. Rest of RoW
9. Pharmaceutical Contract Manufacturing – Market Entropy
   9.1. Expansion
   9.2. Technological Developments
   9.3. Merger & Acquisitions, and Joint Ventures
   9.4. Supply- Contract
10. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)
   10.1. Catalent Pharma Solutions
   10.2. Jubilant Life Sciences Limited
   10.3. Royal DSM N.V.
   10.4. HAUPT Pharma AG
   10.5. Royal DSM N.V.
   10.6. NextPharma
   10.7. Althea Technologies
   10.8. Nipro Corp
   10.9. Abbott Laboratories
   10.10. Kemwell Pvt. Ltd.
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
11. Appendix

   11.1. Abbreviations
   11.2. Sources
   11.3. Research Methodology
   11.4. Bibliography
   11.5. Compilation of Expert Insights
   11.6. Disclaimer
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports
0px;">Scroll